Global Clinical Trials Support Services Market by Phase (Phase I, Phase II, Phase III, Phase
IV) Market by Sponsor (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Other Sponsors) Market by Service (Clinical Trial Site Management, Administrative Services, Patient Recruitment Management, Regulatory Services, Data Management, Other Services) by Geography
• The global clinical trials support services market is expected to reach $40159.64 million by 2030, growing at a 7.65% CAGR during the forecast period, 20222030.
• A clinical trial is a research study in which various experiments or tests are performed on humans and animals, and researchers or investigators then examine the results.
• Thus, clinical trial support services are those that aid in the optimization of the trial process. Support services make the trial process more efficient, from data management to data analysis.
Market by Phase
• Phase I
• Phase II
• Phase III
• Phase IV
Market by Service
• Clinical Trial Site Management
• Administrative Services
• Patient Recruitment Management
• Regulatory Services
• Data Management
• Other Services
Market by Sponsor
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Other Sponsors
• North America: The United States and Canada
• Europe: The United Kingdom, Germany, France, Italy, Spain, Sweden, Denmark, Hungary, and Rest of Europe
• Asia-Pacific: China, Japan, India, South Korea, Taiwan, Singapore, Thailand, Australia & New Zealand, and Rest of Asia-Pacific
• Rest of World: Latin America, the Middle East & Africa
• IQVIA
• Parexel
• Syneos Health
• Labcorp Drug Development
• Clinipace
• Charles River Laboratories Inc
• Medpace
